Combitide Starhaler for Asthma and COPD

Combitide Starhaler for asthma and COPD is a 60-dose dry powder inhaler containing a steroid and a beta agonist formulation. It is designed to treat patients with asthma or COPD, using a novel de-agglomeration engine to separate the drug from the carrier particles. Manufactured by Sun Pharmaceutical Industries Ltd. (Mumbai, India). Entry submitted by Cambridge Consultants Ltd. (Cambridge, UK). Supply and design credit to Design Directions (Pune, India), Sun Pharma Advanced Research Co. Ltd. (Vadodara, India), Foboha GmbH (Haslach, Germany), and Nypro Forbes Pvt. Ltd.

March 26, 2012

1 Min Read
MDDI logo in a gray background | MDDI

Combitide Starhaler for asthma and COPD is a 60-dose dry powder inhaler containing a steroid and a beta agonist formulation. It is designed to treat patients with asthma or COPD, using a novel de-agglomeration engine to separate the drug from the carrier particles. Manufactured by Sun Pharmaceutical Industries Ltd. (Mumbai, India). Entry submitted by Cambridge Consultants Ltd. (Cambridge, UK). Supply and design credit to Design Directions (Pune, India), Sun Pharma Advanced Research Co. Ltd. (Vadodara, India), Foboha GmbH (Haslach, Germany), and Nypro Forbes Pvt. Ltd. (Hosur, India).

MDEA_2012_Finalist_4cSMALL.jpg
 

 

Previous Finalist

Next Finalist

Back to Categories

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like